Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors.

about

Rationale and Design of the Effectiveness of LowEr maintenanCe dose of TicagRelor early After myocardial infarction (ELECTRA) pilot study.

P2860

Q48628910-2FCD5618-603A-46F6-8FB3-EDDE9106E7FE

P2860

Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors.

Item

http://www.wikidata.org/entity/Q38958862

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors.

@en

type

Item

label

Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors.

@en

prefLabel

Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors.

@en

P1476

Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors.

@en

P2093

Diana A Gorog

http://www.w3.org/2001/XMLSchema#string

Eliano P Navarese

http://www.w3.org/2001/XMLSchema#string

Erik L Grove

http://www.w3.org/2001/XMLSchema#string

Ingo Ahrens

http://www.w3.org/2001/XMLSchema#string

Paul A Gurbel

http://www.w3.org/2001/XMLSchema#string

Raffaele De Caterina

http://www.w3.org/2001/XMLSchema#string

Tobias Geisler

http://www.w3.org/2001/XMLSchema#string

Udaya Tantry

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors

Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding

Response variability to P2Y12 receptor inhibitors: expectations and reality

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study

Platelet activation predicts recurrent ischemic events after percutaneous coronary angioplasty: a 6 months prospective study

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation

Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment

P31

scholarly article

P356

10.1093/EHJCVP/PVW044

http://www.w3.org/2001/XMLSchema#string

P50

Jolanta M Siller-Matula

Max-Paul Winter

P577

2017-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28204303

http://www.w3.org/2001/XMLSchema#string

Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors.

about

P2860

P2860

Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P50

P577

P698